Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Martedì 29 giugno 2021
circa 1 minuti di lettura
Journal and Affiliations:
Cell Reports, 29 giugno 2021
Anna De Marco, Humabs BioMed, Bellinzona
Christian Saliba, Humabs BioMed, Bellinzona
Katja Culip, Humabs BioMed, Bellinzona
Elisabetta Cameroni, Humabs BioMed, Bellinzona
Luca Piccoli, Humabs BioMed, Bellinzona
Davide Corti, Humabs BioMed, Bellinzona
Tags:
alpha variant
antibody escape
B.1.1.7
COVID-19
deletion
infectivity
neutralizing antibodies
resistance
SARS-CoV-2
spike mutation
Authors:
Anna De Marco
Christian Saliba
Davide Corti
Elisabetta Cameroni
Katja Culip
Luca Piccoli